RSS

NFLX Netflix Inc.

Last Post: 08/15/24
Followers: 34
Posts Today: 0
Views Today: 1283

NFLX Stock Quote & Tools

$70.3000 ▲ +1.0700 (+1.55%) As of Sep 29, 4:00 PM EDT
Last70.3000
$ Chg1.0700
Open70.3300
High71.3550
Beta1.5256
Year High124.860
Market Cap292.72B
P/B Ratio9.56
EPS3.18
Avg Vol (30d)31.48M
Volume34.55M
% Chg+1.55%
Prev Close69.2300
Low70.1500
VWAP70.50031
Year Low65.080
Total Shares4.16B
Shares Out4.16B
Float4.11B
ExchangeNGS
Media & Telecommunications Traditional Media

NFLX Stock Message Board Discussion

  1. znewcar1

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Nvidia's Major $500 Million Investment in Wayve for AI Expansion

Updated Category News Views 206

Nvidia Invests $500 Million in Wayve Nvidia, known for its advanced AI technologies, is in discussions to invest a substantial $500 million into the U.K.-based autonomous driving startup Wayve. This move marks a significant step for Nvidia as it seeks to deepen its involvement in the rapidly evolving artificial intelligence sector. Strategic Importance of the Investment...

Continue Reading
Vortex Companies Enhances Leadership with Key Promotions

Updated Category News Views 164

Elevating Leadership at Vortex Companies Vortex Companies, known for its rapid growth in the trenchless infrastructure rehabilitation sector, has recently made significant leadership changes with the promotions of Jonathan Thomas and Connor Mathis. Thomas steps into the role of Senior Regional Vice President for the Coastal Region, while Mathis ascends to Regional Vice...

Continue Reading
Scilex Holding Company Receives FDA Acknowledgment for ELYXYB

Updated Category News Views 118

Scilex Holding Company’s FDA Milestone with ELYXYB Scilex Holding Company, based in Palo Alto, California, has gained significant recognition with the U.S. FDA's acknowledgment of their Supplemental New Drug Application (SNDA) for ELYXYB. This marks a substantial step forward for the company, which is dedicated to creating and advancing non-opioid pain management...

Continue Reading
Bio-Techne Expands AI-Driven Protein Portfolio

Updated Category News Views 8

Advanced Proteins in the Spotlight Bio-Techne’s latest move is creating some serious buzz in the life sciences scene. They're not just talking the talk but walking the walk by expanding their R&D Systems AI-Engineered Designer Protein portfolio. What's the big news? They've engineered heat-stable and hyperactive proteins that promise to shake up fibroblast growth factor...

Continue Reading
PolyPid's D-PLEX100 Trial Results Revolutionize Infection Prevention

Updated Category News Views 146

Groundbreaking Advances in Surgical Infection Prevention PolyPid Ltd. has made headlines recently, unveiling remarkable topline results from their pivotal SHIELD II Phase 3 trial. This innovative study showcased D-PLEX100, a major breakthrough in preventing surgical site infections (SSIs), showing statistically significant reductions in both primary and secondary...

Continue Reading